Paul Phillip Walker

Paul Phillip Walker


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
PWPaul Phillip Walker
Paul Phillip Walker
PPPasquale P. Pompilio
Pasquale P. Pompilio
PZPaolo Zanaboni
Paolo Zanaboni
TBTrine Strand Bergmo
Trine Strand Bergmo
KPKaiu Prikk
Kaiu Prikk
Raffaele L. Dellaca'Raffaele L. Dellaca'
Raffaele L. Dellaca'
Rationale: Early detection of chronic obstructive pulmonary disease (COPD) exacerbations using telemonitoring of physiological variables might reduce the frequency of hospitalization. Objectives: To evaluate the efficacy of home monitoring of lung mechanics by the forced oscillation technique and cardiac parameters in older patients with COPD and comorbidities. Methods: This multicenter, randomized clinical trial recruited 312 patients with Global Initiative for Chronic Obstructive Lung Disease grades II to IV COPD (median age, 71 yr [interquartile range, 66–76 yr]; 49.6% grade II, 50.4% grades III–IV), with a history of exacerbation in the previous year and at least one nonpulmonary comorbidity. Patients were randomized to usual care (n = 158) or telemonitoring (n = 154) and followed for 9 months. All telemonitoring patients self-assessed lung mechanics daily, and in a subgroup with congestive heart failure (n = 37) cardiac parameters were also monitored. An algorithm identified deterioration, triggering a telephone contact to determine appropriate interventions. Measurements and Main Results: Primary outcomes were time to first hospitalization (TTFH) and change in the EuroQoL EQ-5D utility index score. Secondary outcomes included: rate of antibiotic/corticosteroid prescription; hospitalization; the COPD Assessment Tool, Patient Health Questionnaire-9, and Minnesota Living with Heart Failure questionnaire scores; quality-adjusted life years; and healthcare costs. Telemonitoring did not affect TTFH, EQ-5D utility index score, antibiotic prescriptions, hospitalization rate, or questionnaire scores. In an exploratory analysis, telemedicine was associated with fewer repeat hospitalizations (−54%; P = 0.017). Conclusions: In older patients with COPD and comorbidities, remote monitoring of lung function by forced oscillation technique and cardiac parameters did not change TTFH and EQ-5D. Clinical trial registered with www.clinicaltrials.gov (NCT 01960907).

1 August 2008 in Thorax
Verified
Journal Article
Open access
PDF file
PWPaul Phillip Walker
Paul Phillip Walker
ABA Burnett
A Burnett
PFP W Flavahan
P W Flavahan
PCP M A Calverley
P M A Calverley
Background: Patients with chronic obstructive pulmonary disease (COPD) walk less than healthy older people and their self-reported activity predicts exacerbation risk. The relationship between lower limb activity and total daily activity is not known, nor are there any data which relate objectively assessed daily activity to laboratory assessments made before and after rehabilitation. Methods: Lower limb activity was measured by leg actigraphy over 3 days in 45 patients with moderate to severe COPD and 18 controls of similar age. Thirty-three patients with COPD entered an 8-week rehabilitation programme in which the change in leg activity was measured and related to other outcomes. Results: In patients with COPD the mean level of activity measured by whole body and leg activity monitors was closely related (r = 0.92; p<0.001), but leg activity was consistently reduced compared with controls of similar age (p = 0.001). Mean leg activity, mean intensity of leg activity and the time that patients spent mobile at home were all related to forced expiratory volume in 1 s (FEV1) (r = 0.57, p = 0.001; r = 0.5, p = 0.003; and r = 0.51, p = 0.002, respectively), but intensity of activity and time spent mobile were not related. Subjects completing pulmonary rehabilitation showed significant improvements in mean activity (p = 0.001) and spent more time moving (p = 0.014). These changes were unrelated to improvement in muscle strength or walking distance but correlated with baseline FEV1 (r = 0.8, p<0.001). Conclusions: Total daily activity in patients with COPD is closely related to leg activity which is reduced compared with controls of similar age. Individuals differ in the time spent mobile during the day, but subjective and objectively assessed activity improves after rehabilitation and is predicted by FEV1. The change in activity is unrelated to improvements in corridor walking and health status.

1 November 2015 in Chest
Verified
Journal Article
Closed access
PWPaul Phillip Walker
Paul Phillip Walker
ETErica Thwaite
Erica Thwaite
SASuzanne Amin
Suzanne Amin
JCJohn M. Curtis
John M. Curtis
PCPeter M.A. Calverley
Peter M.A. Calverley

1 January 2008 in COPD: Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Closed access
PWPaul Phillip Walker
Paul Phillip Walker
PCPeter M. A. Calverley
Peter M. A. Calverley
A significant proportion of patients with COPD show post-bronchodilator improvement in lung volume even though this response is rarely considered when classifying subjects as having reversible or irreversible airway disease. We studied 266 patients with a clinical and physiological diagnosis of COPD who underwent pulmonary function testing and had their spirometric response to 5 mg salbutamol assessed. After the bronchodilator 125 (47%) patients increased their forced vital capacity by more than the known variability of the test while 60 (23%) showed only a volume response without improvement in expiratory flow. These ‘volume responders’ had greater degrees of airflow obstruction–lower FEV1 (p < 0.001) and FEV1/FVC (p < 0.05)—and a higher residual volume at rest (p = 0.005) with similar degrees of emphysema measured by KCO. Subjects with evidence of greater dynamic airway collapse, assessed by the ratio of early to mid expiratory flow, were less likely to have a flow response but more likely to have a volume response after salbutamol (p < 0.005). This would be compatible with volume response being commoner in patients who exhibit tidal expiratory flow limitation. We suggest that post-bronchodilator absolute change in FVC provides important additional physiological information when interpreting bronchodilator reversibility testing.

1 February 2019 in Chest
Verified
Journal Article
Closed access
HBHassan Burhan
Hassan Burhan
RYRyan Young
Ryan Young
TBTara Byrne
Tara Byrne
RPRobert Peat
Robert Peat
JFJennifer Furlong
Jennifer Furlong
PWPaul Phillip Walker
Paul Phillip Walker

23 December 2015 in COPD: Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Closed access
PDF file
NLNadia Lewis-Burke
Nadia Lewis-Burke
BVBen Vlies
Ben Vlies
OWOlivia Wooding
Olivia Wooding
LDLisa Davies
Lisa Davies
PWPaul Phillip Walker
Paul Phillip Walker
Over the last 20 years smoking has become the most common method of heroin use and increasing numbers of heroin smokers are presenting to local medical services, before the age of 40 years, with severe airway disease. To determine COPD prevalence we recruited 129 subjects from two local community drug services, of whom 107 were heroin smokers. We collected demographic, medical and treatment data, smoking history (including cannabis and opiates) and details of symptoms including MRC dyspnoea. Subjects completed the COPD Assessment Tool and spirometry. Thirty heroin smokers were identified as having COPD resulting in a COPD prevalence of 28%. Mean age was 43 (4) Cygan J , Trunsky M , Corbridge T . Inhaled heroin-induced status Asthmaticus: Five cases and a review of the literature. Chest 2000; 117:272–275. [Crossref], [PubMed], [Web of Science ®] , [Google Scholar] years and FEV1 was 2.71 (0.98) L; 70 (23) Doshi V , Shenoy S , Ganesh A , Lankala S , Henkle J . Near fatal asthma in an inner city population. Am J Ther 2014; Oct 3. [Epub ahead of print]. [Web of Science ®] , [Google Scholar] %predicted. Breathlessness and wheeze were more common in subjects with COPD (p < 0.04 and p < 0.05) but symptoms were common in all heroin smokers. MRC score was higher (3 vs. 2.4; p < 0.04) in those with COPD and health status appeared poorer (CAT 20.4 vs. 15.8; p < 0.07). Only 4 (11%) had previously been diagnosed with COPD and only 16 (53%) received any inhaled medication. Asthma prevalence was also high at 33% and asthmatic subjects had similar symptoms and health status compared with the COPD subjects, and were also significantly undertreated. COPD and asthma are common in current and former heroin smokers. They are often present at a young age and are underdiagnosed and undertreated. Awareness of this issue should be highlighted within drug services and in particular to heroin smokers. Screening this high-risk population with spirometry should be considered.